ÂÜÀòÂÒÂ×

Luis M. Salmun

Chief Medical Officer at Kwivik Therapeutics Inc

Luis M. Salmun has over three decades experience in medicine and medical affairs, research, clinical, healthcare insurance, and regulatory registration and approvals; with specialties that include Immunology and Allergy, Asthma, COPD, Cardiovascular Disease, Diabetes and Pediatrics

He is a Former Instructor at Harvard Medical School. Medical Advisor, Asthma & Allergy Foundation of America

His career highlights include: Sr. Vice President, Global Medical Affairs, DBV Technologies; Executive Director, Health Science Executives / Head, Health Science Executives, Boehringer-Ingelheim; Vice President & National Practice Leader, Pulmonary and Immunology – Therapeutic Resource Centers, Medco Health Solutions; Executive Director, Medical Affairs, Mylan (Medical Affairs global responsibilities for the EpiPen auto-injector franchise); Executive Director, WorldWide Consumer Medicines, Bristol-Myers Squibb Company; Sr. Director, Consumer Health Care, Schering-Plough Corporation.

He is widely published, including New England Journal of Medicine, Journal of Allergy and Clinical Immunology, Clinical Therapeutics, Immunology News, Medico Interamericano, and Annals of Allergy and Clinical Immunology.


Org chart